Content
All Posts > Content under Healthcare
Alnylam (ALNY) Stock To Maintain Momentum With New Patent Win
Article By:
KKD Healthcare Analytics
Read
Thursday, June 15, 2017 9:18 AM EDT
Alnylam Pharmaceuticals Inc. boosted its patent portfolio with new allowances from USPTO as the regulatory authority issued the notices with regard to the patent application.
In this article: ALNY
India Globalization Capital's FY'17 Earnings Breakdown
Article By:
The Daily Marijuana Observer
Read
Wednesday, June 14, 2017 7:00 PM EDT
Results reflect a steep cut in expenses associated with the company's renewed focus on its cannabinoid therapy development portfolio.
In this article: IGC
Premarket Biotech Digest – RDHL Initiates Two Products. BMY Starts Recall, PULM Inks New Deal
Article By:
KKD Healthcare Analytics
Read
Wednesday, June 14, 2017 9:07 AM EDT
RedHill Biopharma stock perked up as the company announced starting two GI-focused products in the U.S. Aptose Biosciences stock is on rally as the company announced updates for its pipeline candidates CG'806 and APTO-253.
Look At Fidelity Select Health Care Services Portfolio (FSHCX)
Article By:
Zacks Investment Research
Read
Wednesday, June 14, 2017 7:30 AM EDT
Fidelity Select Health Care Services Portfolio normally invests at least 80% of assets in common stocks of companies principally engaged in the ownership or management of hospitals, nursing homes, and health maintenance organizations.
In this article: FSHCX
Acceleron Pharma Inc. Shares Plummet On Disappointing News From Phase 2 Study Of Dalantercept
Article By:
TickerTV
Read
Tuesday, June 13, 2017 10:51 AM EDT
XLRN opened trading yesterday at $28.91 which was down from the previous day’s trading close of $29.04. XLRN closed trading yesterday at $28.23 and spiked down after market to $26.75, equivalent to a 5% decrease from the closing price.
In this article: XLRN
Upcoming Monitoring System Makes Iradimed A Good Mid-Term Investment
Article By:
KKD Healthcare Analytics
Read
Tuesday, June 13, 2017 10:07 AM EDT
For the second quarter of the year, iRadimed Corp. expects its revenue to be in the range of $5.4 million to $5.5 million while its first quarter revenue stood at $5.2 million.
In this article: IRMD
Monday, Monday
Article By:
Marvin R Clark
Read
Tuesday, June 13, 2017 1:08 AM EDT
The Dow Industrials fell from record highs, with an inside trading session that does not look like a reversal, not yet anyway. The Nasdaq Composite confirmed its sharp downturn on Friday.
Sensex Opens Flat; Sun Pharma Gains Over 3% On USFDA Approval
Article By:
Equitymaster India
Read
Tuesday, June 13, 2017 12:33 AM EDT
Share markets in India have opened the day on a flat note with the positive bias. The BSE Sensex is trading higher by 43 points while the NSE Nifty is trading higher by 7 points.
3 Large Cap Pharma Stocks To Buy Now
Article By:
Zacks Investment Research
Read
Monday, June 12, 2017 3:59 PM EDT
The healthcare sector has dominated headlines this year thanks to promises from the GOP and the Trump administration related to repealing and replacing Obamacare.
Iomab-B Makes Actinium Pharma A Rare And Exciting Investment Opportunity
Article By:
Jason Napodano
Read
Monday, June 12, 2017 1:41 PM EDT
BMT is one of the fastest growing hospital procedures according to AHRQ; US Dept. of HHS. Iomab-B offers a better solution - cheaper, faster, safer, and more effective - than the current standard of care.
In this article: ATNM